BFRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Biofrontera Inc (BFRI) is not a strong buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock lacks positive momentum, has weak financial performance, and no significant catalysts or trading signals to support an immediate investment decision. Holding off on this stock is recommended.
The MACD is slightly positive but contracting, RSI is neutral at 40.973, and moving averages are converging, indicating no clear trend. The stock is trading below its pivot point of 0.881, with key support at 0.824 and resistance at 0.938.
Gross margin improved significantly to 70.74%, up 54.18% YoY.
Revenue dropped by -22.46% YoY, EPS decreased by -36.73% YoY, and the stock has shown a consistent downward trend in recent trading sessions with no news or events to drive positive sentiment.
In Q3 2025, revenue dropped to $6.99M (-22.46% YoY), net income improved slightly but remains negative at -$6.65M (+17.29% YoY), and EPS fell to -0.62 (-36.73% YoY).
No recent analyst ratings or price target changes available.
